SEC Form 4 · accession 0000899243-19-003146

Ocugen, Inc. · OCGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Feb 8, 2019

Accepted (ET)

Feb 11, 2019 · 4:26 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001372299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Feb 8, 2019	M	403,845	—	A	4,014,415	I	See Footnote
Common Stock^F1,F2	Feb 8, 2019	M	1,244,444	—	A	5,258,859	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Common Stock Warrant (Right to Buy)^F1,F2	$0.01	Feb 8, 2019	M	403,845	A	Oct 10, 2018	Oct 10, 2023	Common Stock	403,845	0	I
Common Stock Warrant (Right to Buy)^F1,F2	$0.01	Feb 8, 2019	M	1,244,444	A	Nov 22, 2016	Nov 22, 2021	Common Stock	1,244,444	0	I

F1The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019.
F2The reportable securities are owned by Wilmslow Estates Limited. The Reporting Person has no beneficial interest in the trust which ultimately owns the economic interest in Wilmslow Estates Limited, but other members of the Reporting Person's family are discretionary beneficiaries in such trust. To the extent the Reporting Person may be deemed to hold an indirect beneficial interest under applicable United States securities laws, the Reporting Person disclaims such beneficial interest. The Reporting Person disclaims beneficial ownership of these shares and this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.